GlassScriptPhysician profile
Jenna Brkich
NPI 1891146882
$24,871.82
in general payments reported to CMS, 2019-2025
30 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.66 · 2021: $978 · 2022: $871 · 2023: $2,648 · 2024: $9,102 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $5,773 · Travel and Lodging: $4,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,115.00 |
| Food and Beverage | $5,772.83 |
| Travel and Lodging | $4,103.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flower Orthopedics Coporation | $12,053.79 | 2023-2025 | Fibula Nail, 4.5mm X 180mm, Titanium, Flex-Thread, Zero Profile Interlocking Cortex Screw, 2.7mm X 14mm, T8, Flex-Thread, Fibula Nail, 3.5mm X 130mm, Titanium, Flex-Thread |
| Medical Device Business Services, INC. | $4,436.62 | 2021-2025 | Motoband |
| Stryker Corporation | $3,413.18 | 2021-2025 | Hoffmann, Salvation, Augment Injectable |
| Depuy Synthes Sales INC. | $1,742.67 | 2020-2025 | Va-Lcp, Na, Motoband |
| Smith+Nephew, INC. | $724.71 | 2021-2025 | Stravix, Stravix Mesh, Grafix Pl |
| Abbvie INC. | $466.66 | 2021-2024 | |
| Carbofix Orthopedics INC | $264.05 | 2025 | |
| Bonalive INC | $260.67 | 2025 | |
| Kuros Biosciences USA, INC | $188.62 | 2025 | Magnetos |
| Acera Surgical, INC. | $180.26 | 2024 | Restrata Wound Matrix |
| Alafair Biosciences, INC. | $168.83 | 2025 | Versawrap |
| Paragon 28, INC. | $163.02 | 2023-2025 | Phantom Fibula Nail, Portfolio |
| Axogen | $118.78 | 2021-2023 | Avance Nerve Graft |
| Aroa Biosurgery Incorporated | $107.02 | 2023 | |
| Paratek Pharmaceuticals, INC. | $89.60 | 2022-2024 | Nuzyra |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $87.34 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Nevro Corp. | $69.59 | 2023-2024 | Senza |
| Kci USA, INC. | $51.22 | 2023 | Prevena, Activ.A.C., Promogran Prisma |
| Avita Medical Americas, LLC | $37.74 | 2024 | |
| Orthofix Medical, INC. | $34.35 | 2024 | Physio-Stim |
| Lifenet Health | $29.82 | 2025 | Theragenesis Wound Matrix |
| Highridge Medical LLC | $27.27 | 2024 | Biomet Ebi Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $26.18 | 2024 | |
| Zimvie INC. | $23.26 | 2024 | |
| Zimmer Biomet Holdings, INC. | $23.07 | 2021 | |
| Next Science LLC | $20.32 | 2023 | Surgx, Blastx, Xperience |
| Arbor Pharmaceuticals, INC. | $18.98 | 2021 | |
| Urgo Medical North America, LLC | $16.01 | 2023 | Urgok2 |
| Treace Medical Concepts, INC. | $15.50 | 2025 | |
| Integra Lifesciences Corporation | $12.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Brkich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.